Dem Governors Launch Health Association to Challenge CDC and FDA Authority

What Happened

A coalition of Democratic governors has launched a new group. It’s aimed at shaping public health policy independently from federal agencies like the Centers for Disease Control and Prevention and the Food and Drug Administration. The organization, called the Governors’ Public Health Association, claims it’s nonpartisan and rooted in science and public trust. All of its founding members are Democrats.

The association includes governors from states such as California, New York, Illinois, Massachusetts, Washington, and a dozen others, along with the territory of Guam. Their stated goal is to issue joint health guidance on issues ranging from vaccines to emergency preparedness and public messaging. That guidance could differ from what federal agencies recommend.

The group says it will share data among member states and coordinate messaging to counter what it describes as misinformation and political interference. Critics argue the move adds more politics, not less, to public health. They warn it risks deepening confusion at a time when trust in major health institutions is already under strain.

Why It Matters

This is a direct challenge to the role of federal agencies in managing public health across the country. The CDC and FDA have long served as the central sources of guidance on vaccines, medication approvals, and emergency response. If states start going their own way, the result could be a fragmented system with conflicting rules and standards.

“One of the Largest Industries Ever”

That’s what NVIDIA’s CEO said about robotics. And the numbers back it up. In Q4 2024, the sector raised nearly more capital than in all of 2023. 

So it’s a big deal that both NVIDIA and Amazon helped Miso Robotics* perfect Flippy, its new fully commercial kitchen robot. No wonder initial units sold out in one week.

Miso already has 200K+ hours for brands like White Castle under its belt. With the $1T fast-food industry facing 144% labor turnover rates, Flippy provides 24/7 labor and can boost profits by up to 3X.

Now, Miso is scaling its US-based manufacturing to seize a $4B/year revenue opportunity. And you can still invest in Miso until October 23, the final day to invest this year.

The governors behind the effort say their goal is to “restore trust in science.” That message may fall flat with Americans who remember how these same leaders handled the COVID pandemic. Their approach often involved heavy-handed restrictions, shifting rules, and mixed messaging.

Critics, including officials within the Department of Health and Human Services, have pointed out the irony. The same governors who now claim to be correcting the system played a major role in damaging public confidence in the first place.

This new group could also complicate logistics. Health insurers, pharmaceutical companies, and hospitals typically operate across state lines. If a state-level alliance issues rules that clash with federal standards, it opens the door to legal conflicts, insurance discrepancies, and breakdowns in coordination during national emergencies.

How It Affects You

If you live in one of the member states, you may soon see public health guidance that does not align with what the CDC or FDA recommends. That could affect vaccine availability, eligibility for certain treatments, or what protocols are followed during health emergencies. You may also see different information campaigns, terminology, or state-level rules that conflict with federal guidance.

For businesses that operate in multiple states, this could increase regulatory uncertainty. If your company follows federal rules but your state issues conflicting guidance, it’s unclear which standard holds legal weight. That affects compliance, liability, and costs.

This also raises a larger question about where health policy should be made. If you believe in the importance of consistent national standards, this development may be concerning. It suggests a move toward a fractured approach where each state charts its own course. This could undermine emergency preparedness and public trust. On the other hand, if you support state sovereignty and local control, this may seem like a long-overdue check on bloated federal agencies that have lost the public’s confidence.

No matter your view, it’s clear that the CDC and FDA may no longer be the final word on public health across the country.

*This is a paid advertisement for Miso Robotics’ Regulation A offering. Please read the offering circular at invest.misorobotics.com.